Treatment News : Depression More Common Among HIV-Positive Women Than Men

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » January 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

January 11, 2012

Depression More Common Among HIV-Positive Women Than Men

Depression is more common among women living with HIV, compared with men living with HIV, according to an international study reported at the 2nd International Workshop on HIV and Women, held January 9 and 10 in Bethesda, Maryland, and highlighted by the National AIDS Treatment Advocacy Project (NATAP).

Though there has been scientific evidence pointing to higher rates of depression among HIV-positive women compared with HIV-positive men, the vast majority of studies exploring rates of mental illness in people living with HIV have not reported findings by gender.

In turn, investigators associated with the CRANIum Study, conducted in Europe and Canada, compared depression rates among people living with HIV—with a high proportion being women—currently receiving antiretroviral (ARV) therapy and those who haven’t yet started HIV treatment. The researchers used the Hospital Anxiety and Depression Scale (HADS), a 14-question survey used to screen for depression and anxiety.

Of the 2,863 questionnaire participants, roughly 38 percent were women, nearly 79 percent of whom had at least some history of ARV therapy. The average age of both men and women in the study was 43. The male participants were more likely to be white (86 percent versus 67 percent) and to have been living with HIV for a shorter period (90 months versus 112 months).

According to NATAP’s report of the investigator’s presentation, a significantly higher proportion of women met criteria for depression: 18 percent versus 14 percent, respectively. This difference was statistically significant, meaning that it was too great to have occurred by chance. Additionally, rates of depression were no different among women who were receiving ARV therapy, compared with those who were not. Of note, however, the rate of depression was significantly higher among HIV-positive women not yet receiving ARV therapy compared with HIV-positive men not yet on treatment (21 percent versus 11 percent).

The CRANIum investigators believe their findings “support a strategy of regular screening for, and clinical management of, anxiety and depression for all female HIV-infected patients,” NATAP reports.

Search: depression, women, men, prevalence, CRANIum study, Europe, Canada


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (2 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.